Voor de beste ervaring schakelt u JavaScript in en gebruikt u een moderne browser!
Je gebruikt een niet-ondersteunde browser. Deze site kan er anders uitzien dan je verwacht.

M. (Maryam) Soleimani Dodaran MSc

Faculteit der Natuurwetenschappen, Wiskunde en Informatica
Swammerdam Institute for Life Sciences

Bezoekadres
  • Science Park 904
Postadres
  • Postbus 1212
    1000 BE Amsterdam
Contactgegevens
  • Publicaties

    2020

    • Borgoni, S., Sofyali, E., Soleimani, M., Wilhelm, H., Müller-Decker, K., Will, R., Noronha, A., Beumers, L., Verschure, P. J., Yarden, Y., Magnani, L., van Kampen, A. H. C., Moerland, P. D., & Wiemann, S. (2020). Time-Resolved Profiling Reveals ATF3 as a Novel Mediator of Endocrine Resistance in Breast Cancer. Cancers, 12(10), [2918]. https://doi.org/10.3390/cancers12102918 [details]
    • Soleimani Dodaran, M., Borgoni, S., Sofyali, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & van Kampen, A. H. C. (2020). Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2-breast cancer. BMC Cancer, 20, [676]. https://doi.org/10.1186/s12885-020-07100-z [details]

    2020

    • Sofyall, E., Wiemann, S., Soleimani Dodaran, M., Moerland, P. D., Borgoni, S., Verschure, P. & van Kampen, A. (1-1-2020). Additional file 10 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673794.v1
    • Verschure, P., Wiemann, S., Moerland, P. D., Soleimani Dodaran, M., van Kampen, A., Sofyall, E. & Borgoni, S. (1-1-2020). Additional file 15 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673809.v1
    • Soleimani Dodaran, M., Borgoni, S., Moerland, P. D., Wiemann, S., Sofyall, E., Verschure, P. & van Kampen, A. (1-1-2020). Additional file 6 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673827.v1
    • Moerland, P. D., Borgoni, S., van Kampen, A., Verschure, P., Sofyall, E., Wiemann, S. & Soleimani Dodaran, M. (1-1-2020). Additional file 11 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673797.v1
    • Verschure, P., Borgoni, S., Sofyall, E., Soleimani Dodaran, M., Wiemann, S., Moerland, P. D. & van Kampen, A. (1-1-2020). Additional file 5 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673824.v1
    • Verschure, P., van Kampen, A., Borgoni, S., Wiemann, S., Moerland, P. D., Soleimani Dodaran, M. & Sofyall, E. (1-1-2020). Additional file 14 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673806.v1
    • Borgoni, S., Wiemann, S., Verschure, P., Soleimani Dodaran, M., Moerland, P. D., Sofyall, E. & van Kampen, A. (1-1-2020). Additional file 12 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673800.v1
    • Sofyall, E., van Kampen, A., Borgoni, S., Moerland, P. D., Wiemann, S., Soleimani Dodaran, M. & Verschure, P. (1-1-2020). Additional file 1 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673812.v1
    • Borgoni, S., Soleimani Dodaran, M., van Kampen, A., Sofyall, E., Wiemann, S., Moerland, P. D. & Verschure, P. (1-1-2020). Additional file 13 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673803.v1
    • Sofyall, E., van Kampen, A., Verschure, P., Moerland, P. D., Borgoni, S., Wiemann, S. & Soleimani Dodaran, M. (1-1-2020). Additional file 9 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673836.v1
    • Borgoni, S., Wiemann, S., Verschure, P., Moerland, P. D., Soleimani Dodaran, M., Sofyall, E. & van Kampen, A. (1-1-2020). Additional file 4 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673821.v1
    • van Kampen, A., Verschure, P., Wiemann, S., Soleimani Dodaran, M., Moerland, P. D., Sofyall, E. & Borgoni, S. (1-1-2020). Additional file 2 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673815.v1
    • Borgoni, S., Moerland, P. D., Verschure, P., van Kampen, A., Sofyall, E., Wiemann, S. & Soleimani Dodaran, M. (1-1-2020). Additional file 8 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673833.v1
    • Soleimani Dodaran, M., Sofyall, E., Borgoni, S., van Kampen, A., Moerland, P. D., Verschure, P. & Wiemann, S. (1-1-2020). Additional file 7 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673830.v1
    • Soleimani Dodaran, M., Verschure, P., Borgoni, S., Wiemann, S., Moerland, P. D., Sofyall, E. & van Kampen, A. (1-1-2020). Additional file 3 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. figshare Academic Research System. https://doi.org/10.6084/m9.figshare.12673818.v1
    This list of publications is extracted from the UvA-Current Research Information System. Questions? Ask the library or the Pure staff of your faculty / institute. Log in to Pure to edit your publications. Log in to Personal Page Publication Selection tool to manage the visibility of your publications on this list.
  • Nevenwerkzaamheden
    Geen nevenwerkzaamheden